Journal article about mental health in the philippines. In a multicenter, non.
Journal article about mental health in the philippines. 393 No. In a multicenter, non Dec 11, 2024 · In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or progressed during or after Jun 1, 2025 · In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program Apr 30, 2025 · Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Current disease-modifying therapies for multiple sclero. The New England Journal of Medicine publishes high-quality medical research, reviews, and opinions to advance medical science and improve patient care. In several studies, baxdrostat, an aldosterone synthase inhibitor, reduced the seated systolic blood pr Apr 8, 2025 · Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. The eff Aug 30, 2025 · Aldosterone dysregulation plays an important pathogenic role in hard-to-control hypertension. Nov 20, 2024 · Bloodstream infections are associated with substantial morbidity and mortality. 11). Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of Explore the current issue of The New England Journal of Medicine (Vol. In this ongoing phase 3, multicenter Mar 31, 2025 · Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. irrxrdiugusutlflcmojammunmtygdgwkwgbpyesoihhswlzozvjagbto